Prelude Therapeutics Incorporated Share Price
PRLDPrelude Therapeutics Incorporated Stock Performance
Open $3.17 | Prev. Close $3.11 | Circuit Range N/A |
Day Range $3.17 - $3.41 | Year Range $0.61 - $4.18 | Volume 12,592 |
Average Traded $3.27 |
Prelude Therapeutics Incorporated Share Price Chart
About Prelude Therapeutics Incorporated
Prelude Therapeutics Incorporated, a clinical-stage precision oncology company, focuses on the discovery and development of novel precision cancer medicines to underserved patients. It is developing PRT3789, a selective degrader of SMARCA2 protein for the treatment of advanced or metastatic solid tumors with loss of SMARCA4 due to truncating mutation and/or deletion; PRT7732, a selective and orally bioavailable SMARCA2 degraders to treat advanced or metastatic solid tumors; and PRT2527, a cyclin-dependent kinase 9 inhibitor for the treatment of advanced solid tumors. The company's CDK9 program is a regulator of cancer-promoting transcriptional programs, including MCL1, MYC, and MYB. Prelude Therapeutics Incorporated was incorporated in 2016 and is based in Wilmington, Delaware.
Prelude Therapeutics Incorporated Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
18-Mar-26 | $3.23 | $3.11 | -9.59% |
17-Mar-26 | $3.45 | $3.44 | +2.23% |
16-Mar-26 | $3.31 | $3.37 | +1.97% |
13-Mar-26 | $3.28 | $3.30 | -1.64% |
12-Mar-26 | $3.57 | $3.35 | -12.63% |
11-Mar-26 | $3.71 | $3.84 | +7.56% |
10-Mar-26 | $3.19 | $3.57 | +16.29% |
FAQs on Prelude Therapeutics Incorporated Share Price
Can I buy Prelude Therapeutics Incorporated shares in India?
What is the share price of Prelude Therapeutics Incorporated?
What is the 5 year returns of Prelude Therapeutics Incorporated?
What are the high & low stock price of Prelude Therapeutics Incorporated today?
What is the 52-week high and low of Prelude Therapeutics Incorporated stock?